Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i> -associated retinitis pigmentosa: a non-randomised controlled trial

Subretinal gene therapy with AAV8.hPDE6A did not improve visual function over 1 year and posed risks, including central retinal thinning and visual acuity decline. This is in contrast to the safety and efficacy profile established in preclinical models.

Authors

Institutions

Publication Details

Journal
British Journal of Ophthalmology
Published
2025-08-18
DOI
https://doi.org/10.1136/bjo-2024-326480
Primary Topic
Retinal Development and Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and vision outcomes of subretinal gene supplementation therapy in PDE6A -associated retinitis pigmentosa: a non-randomised controlled trial

M. Ziégler, Stylianos Michalakis, Susanne Kohl, Nicole Weisschuh et al.
British Journal of Ophthalmology
Retinal Development and Disorders
article

Safety and vision outcomes of subretinal gene supplementation therapy in PDE6A -associated retinitis pigmentosa: a non-randomised controlled trial

M. Ziégler, Stylianos Michalakis, Susanne Kohl, Nicole Weisschuh, Marius Ueffing, Stephen H. Tsang, Immanuel P. Seitz, Regine Muehlfriedel, Eberhart Zrenner, Barbara Wilhelm, Laura Kuehlewein, Peter Martus, Felix F. Reichel, Bernd Wissinger, François Paquet‐Durand, Katarína Štingl, Mathias W. Seeliger, Martin Biel, Tobias Peters, Karl Ulrich Bartz-Schmidt, M. Dominik Fischer
article en

Abstract

Subretinal gene therapy with AAV8.hPDE6A did not improve visual function over 1 year and posed risks, including central retinal thinning and visual acuity decline. This is in contrast to the safety and efficacy profile established in preclinical models.

British Journal of OphthalmologyVol. 110(2)
LMU Klinikum (DE), University of Oxford (GB), University Children's Hospital Tübingen (DE), STZ eyetrial (DE), Columbia University (US), University of Tübingen (DE), Ludwig-Maximilians-Universität München (DE)
Tistou and Charlotte Kerstan Stiftung
Openalex Percentile: Top 81%
Retinal Development and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.